Pontos Group
VC Fund
Helsinki, Finland
Pontos Group is a VC fund in Helsinki focused on Genetics and Hospital. Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Pontos Group invests in
Stages Pontos Group invests in
Countries Pontos Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Investment Focus
Industry
- Genetics 1 (25%)
- Hospital 1 (25%)
- Automotive 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Päivi Tomula
Investment Director, Real Estate
|
Investment Director, Real Estate | Total investments: 0 | Find email | |
Terhi Kauppi
CFO
|
CFO | Total investments: 0 | Find email | |
Timo Kokkila
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
R8tech
|
R8tech take building technical management to the next generation by adding Artificial Intelligence on top of existing automation system. Our solution enables clients to take intelligent and automated control over their HVAC (Heating-Ventilating-Air Cooling) systems 24/7 and achieve energy costs savings and CO2 emission reduction up to -20%together with a better indoor comfort and improve HVAC transparency and stability with novel fault diagnostics features. R8tech ensures that buildings are heated, cooled and ventilated at the right time, with the right amount of energy as our AI engine takes account the constant fluctuations of visitors, weather and energy market prices. | Seed / Jun 01, 2018 | |
Blueprint Genetics
|
Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinicalinsight to the results statements.The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.The company is based in Helsinki, Finland and has an office also in Los Angeles, CA. | $15.4M / Jul 11, 2017 | |
|
Blueprint Genetics
|
Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinicalinsight to the results statements.The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.The company is based in Helsinki, Finland and has an office also in Los Angeles, CA. | $6.6M / Dec 31, 2016 | |
Valmet Automotive
|
Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca | $21.9M / Nov 08, 2010 |
Co-Investors
Inventure
2 deals together
Creathor Ventures
1 deal together
MTIP AG
1 deal together
Stanford University
1 deal together
Tesi
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pontos Group invest in?
Pontos Group invests primarily in Genetics, Hospital and Automotive startups, most often at Funding Round stage. Most of the 4 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pontos Group?
Public channels for Pontos Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pontos Group?
The team at Pontos Group includes Päivi Tomula (Investment Director, Real Estate), Terhi Kauppi (CFO) and Timo Kokkila (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
